Page last updated: 2024-11-04

s-methylisothiopseudouronium and Cardiomyopathies

s-methylisothiopseudouronium has been researched along with Cardiomyopathies in 1 studies

S-methylisothiopseudouronium: inhibits nitric oxide synthase; structure in first source

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgarten, G1
Knuefermann, P1
Schuhmacher, G1
Vervölgyi, V1
von Rappard, J1
Dreiner, U1
Fink, K1
Djoufack, C1
Hoeft, A1
Grohé, C1
Knowlton, AA1
Meyer, R1

Other Studies

1 other study available for s-methylisothiopseudouronium and Cardiomyopathies

ArticleYear
Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia.
    Shock (Augusta, Ga.), 2006, Volume: 25, Issue:1

    Topics: Animals; Cardiomyopathies; Cells, Cultured; Endotoxemia; Enzyme Inhibitors; Gram-Negative Bacterial

2006